Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis

Authors
Lund, BC Neiman, RF Perry, PJ
Citation
Bc. Lund et al., Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis, PHARMACOTHE, 19(12), 1999, pp. 1437-1438
Citations number
15
Categorie Soggetti
Pharmacology
Journal title
PHARMACOTHERAPY
ISSN journal
02770008 → ACNP
Volume
19
Issue
12
Year of publication
1999
Pages
1437 - 1438
Database
ISI
SICI code
0277-0008(199912)19:12<1437:TOPDWR>2.0.ZU;2-0
Abstract
Pergolide is a dopaminergic agonist used to treat Parkinson's disease but i s associated with the development of retroperitoneal fibrosis (RPF). Newer nonergot agents (pramipexole, ropinirole) may not carry this same risk. A p atient with a history of pergolide-induced RPF was treated successfully wit h ropinirole for 1 year without complications.